These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1841810)

  • 41. Current issues in hypertension research and therapy.
    MacFadyen RJ; Prasad N
    Br J Hosp Med; 1995 Apr 5-18; 53(7):335-43. PubMed ID: 7788073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of hypertension in patients with diabetes mellitus.
    Agarwal R
    Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
    [No Abstract]   [Full Text] [Related]  

  • 44. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 45. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does combination therapy with a calcium channel blocker and an ACE inhibitor have additive effects on blood pressure reduction?
    Edelman DA; Paul RA
    Int J Clin Pract; 2000 Mar; 54(2):105-9. PubMed ID: 10824365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers.
    Caldwell BV
    Clin Ther; 1993; 15(4):618-36; discussion 617. PubMed ID: 8221813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage.
    Raij L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():23-7. PubMed ID: 8643203
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin converting enzyme inhibition and calcium channel blockade as primary antihypertensive therapy.
    Bühler FR; Müller FB
    J Hypertens Suppl; 1986 Dec; 4(5):S435-40. PubMed ID: 3033183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The current therapy of hypertension].
    Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):85-8. PubMed ID: 1841810
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.